208 related articles for article (PubMed ID: 21203466)
1. The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma.
Al-Moundhri MS; Al-Nabhani M; Tarantini L; Baccarelli A; Rusiecki JA
PLoS One; 2010 Dec; 5(12):e15585. PubMed ID: 21203466
[TBL] [Abstract][Full Text] [Related]
2. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
[TBL] [Abstract][Full Text] [Related]
3. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
[TBL] [Abstract][Full Text] [Related]
4. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
5. Global DNA methylation and tumor suppressor gene promoter methylation and gastric cancer risk in an Omani Arab population.
Rusiecki JA; Al-Nabhani M; Tarantini L; Chen L; Baccarelli A; Al-Moundhri MS
Epigenomics; 2011 Aug; 3(4):417-29. PubMed ID: 22126203
[TBL] [Abstract][Full Text] [Related]
6. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori Eradication Modulates Aberrant CpG Island Hypermethylation in Gastric Carcinogenesis.
Choi J; Kim SG; Kim BG; Koh SJ; Kim JW; Lee KL
Korean J Gastroenterol; 2016 Nov; 68(5):253-259. PubMed ID: 27871161
[TBL] [Abstract][Full Text] [Related]
8. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
12. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
[TBL] [Abstract][Full Text] [Related]
13. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
14. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment.
Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A
Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570
[TBL] [Abstract][Full Text] [Related]
16. BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.
Mikata R; Fukai K; Imazeki F; Arai M; Fujiwara K; Yonemitsu Y; Zhang K; Nabeya Y; Ochiai T; Yokosuka O
Oncol Rep; 2010 Jun; 23(6):1701-8. PubMed ID: 20428828
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
18. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.
Abbaszadegan MR; Moaven O; Sima HR; Ghafarzadegan K; A'rabi A; Forghani MN; Raziee HR; Mashhadinejad A; Jafarzadeh M; Esmaili-Shandiz E; Dadkhah E
World J Gastroenterol; 2008 Apr; 14(13):2055-60. PubMed ID: 18395906
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia.
Waki T; Tamura G; Sato M; Terashima M; Nishizuka S; Motoyama T
Cancer Sci; 2003 Apr; 94(4):360-4. PubMed ID: 12824905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]